Changes in expression levels of excision repair cross-complementing group 1 (ERCC1) and dihydropyrimidine dehydrogenase (DPD) after first-line oxaliplatin-based chemotherapy for metastatic colorectal cancer: Results of a multicenter study.
Hideo Baba
No relevant relationships to disclose
Yoshifumi Baba
No relevant relationships to disclose
Shinji Uemoto
No relevant relationships to disclose
Eiji Oki
No relevant relationships to disclose
Yasuharu Ikeda
No relevant relationships to disclose
Masakazu Yamamoto
No relevant relationships to disclose
Hiroyuki Matsuda
No relevant relationships to disclose
Mitsuo Shimada
Research Funding - Chugai Pharma; Taiho Pharmaceutical; Yakult
Norihiro Kokudo
No relevant relationships to disclose